5/25/2025
Last update
5/25/2025
Reviewed By
Overview
SCIENTIFIC SCORE
Questionable
Based on 23 Researches
6.6
USERS' SCORE
Moderately Good
Based on 63 Reviews
7.6
Supplement Facts
Serving Size: 2 Tablets
Amount Per Serving
%DV
Magnesium (from 2,000 mg magnesiumlysinate glycinate chelate) (Albion®)
200 mg
48%
Top Medical Research Studies
9
We explored the potential of magnesium implantation as a new approach to combat heart attacks, specifically myocardial infarction (MI). Our research centered on using magnesium slices implanted under the skin of rats to generate hydrogen gas continuously. This method could ensure a greater and longer-lasting concentration of hydrogen directly reaching the heart, which is crucial for its therapeutic effects.
Through our study, we measured how effectively the magnesium produced hydrogen and evaluated its safety. The results were promising; we observed that magnesium implantation not only improved cardiac function in rats suffering from MI, but also played a role in eliminating harmful free radicals from mitochondrial dysfunction. Furthermore, it helped reduce cell death in heart muscle cells, which is a common consequence of heart attacks.
Compared to traditional hydrogen inhalation, which has limitations in delivering sufficient doses over time, magnesium implantation proved to be a superior method. Overall, our findings pave the way for innovative treatments that could enhance recovery after heart attacks by harnessing the unique properties of magnesium for hydrogen production.
Through our study, we measured how effectively the magnesium produced hydrogen and evaluated its safety. The results were promising; we observed that magnesium implantation not only improved cardiac function in rats suffering from MI, but also played a role in eliminating harmful free radicals from mitochondrial dysfunction. Furthermore, it helped reduce cell death in heart muscle cells, which is a common consequence of heart attacks.
Compared to traditional hydrogen inhalation, which has limitations in delivering sufficient doses over time, magnesium implantation proved to be a superior method. Overall, our findings pave the way for innovative treatments that could enhance recovery after heart attacks by harnessing the unique properties of magnesium for hydrogen production.
Read More
8
We examined whether serum magnesium levels at admission could predict in-hospital outcomes for patients experiencing a heart attack.
In our study of 259 acute myocardial infarction patients, those with lower magnesium levels (below 1.82 mg/dl) faced significantly higher risks of complications, including arrhythmias and even death, compared to those with healthier levels.
Our findings suggest that maintaining adequate magnesium levels is essential for better health outcomes after a heart attack.
In our study of 259 acute myocardial infarction patients, those with lower magnesium levels (below 1.82 mg/dl) faced significantly higher risks of complications, including arrhythmias and even death, compared to those with healthier levels.
Our findings suggest that maintaining adequate magnesium levels is essential for better health outcomes after a heart attack.
Read More
5
OCT and angiography show comparable effectiveness
We examined how two guidance methods—optical coherence tomography (OCT) and angiography—perform during magnesium bioresorbable scaffold (MBRS) implantation in patients recovering from a non-ST-elevation heart attack.
With 75 participants, our study revealed that both techniques resulted in comparable healing patterns after six months. Though OCT-guided intervention showed slightly better outcomes in certain technical measures, neither approach demonstrated a significant advantage in overall heart healing.
Thus, for NSTEMI patients, choosing between OCT and angiography for MBRS placement may depend on other factors, as both methods appear effective.
With 75 participants, our study revealed that both techniques resulted in comparable healing patterns after six months. Though OCT-guided intervention showed slightly better outcomes in certain technical measures, neither approach demonstrated a significant advantage in overall heart healing.
Thus, for NSTEMI patients, choosing between OCT and angiography for MBRS placement may depend on other factors, as both methods appear effective.
Read More
Most Useful Reviews
9
Supports heart function
138 people found this helpful
Following a heart attack, magnesium has been very beneficial for my body in maintaining normal cardiovascular function. I now take this supplement regularly to prevent future issues.
Read More
10
Palpitations relieved
24 people found this helpful
I felt almost debilitating heart palpitations for two years and was always worried about having a heart attack. After numerous medical tests, I tried this supplement and, within hours, my palpitations stopped. It has been life-changing! I feel much sharper and free of anxiety and am hopeful that I can maintain this health long-term.
Read More
9
Palpitations resolved
21 people found this helpful
I started taking magnesium to address heart palpitations caused by birth control pills. Since switching to this absorbed form, I've not experienced any incidents. Truly fantastic!
Read More
Medical Researches
SCIENTIFIC SCORE
Questionable
Based on 23 Researches
6.6
- All Researches
9
We explored the potential of magnesium implantation as a new approach to combat heart attacks, specifically myocardial infarction (MI). Our research centered on using magnesium slices implanted under the skin of rats to generate hydrogen gas continuously. This method could ensure a greater and longer-lasting concentration of hydrogen directly reaching the heart, which is crucial for its therapeutic effects.
Through our study, we measured how effectively the magnesium produced hydrogen and evaluated its safety. The results were promising; we observed that magnesium implantation not only improved cardiac function in rats suffering from MI, but also played a role in eliminating harmful free radicals from mitochondrial dysfunction. Furthermore, it helped reduce cell death in heart muscle cells, which is a common consequence of heart attacks.
Compared to traditional hydrogen inhalation, which has limitations in delivering sufficient doses over time, magnesium implantation proved to be a superior method. Overall, our findings pave the way for innovative treatments that could enhance recovery after heart attacks by harnessing the unique properties of magnesium for hydrogen production.
Through our study, we measured how effectively the magnesium produced hydrogen and evaluated its safety. The results were promising; we observed that magnesium implantation not only improved cardiac function in rats suffering from MI, but also played a role in eliminating harmful free radicals from mitochondrial dysfunction. Furthermore, it helped reduce cell death in heart muscle cells, which is a common consequence of heart attacks.
Compared to traditional hydrogen inhalation, which has limitations in delivering sufficient doses over time, magnesium implantation proved to be a superior method. Overall, our findings pave the way for innovative treatments that could enhance recovery after heart attacks by harnessing the unique properties of magnesium for hydrogen production.
Read More
9
Magnesium scaffolds improve heart attack outcomes
We examined the performance of two types of bioresorbable scaffolds in patients experiencing acute coronary syndrome (ACS) - a common and serious manifestation of heart disease. Specifically, we compared the effectiveness of magnesium-based scaffolds, known as Magmaris, with the earlier polymer scaffolds called Absorb.
Our study included 193 patients using Magmaris and 160 patients using Absorb, all treated in similar clinical settings. Over the course of one year, we monitored their health outcomes, particularly focusing on serious issues like cardiac death, heart attacks, and instances of scaffold thrombosis.
Surprisingly, we found that patients with Magmaris had significantly better outcomes than those with Absorb. Specifically, the rates of primary complications and target lesion failures were notably lower with Magmaris. We noted a concerning trend with Absorb, where patients experienced a higher rate of scaffold thrombosis.
Overall, our findings suggest that magnesium-based scaffolds could provide a safer and more effective option for patients undergoing treatment for heart attacks compared to their polymer counterparts.
Our study included 193 patients using Magmaris and 160 patients using Absorb, all treated in similar clinical settings. Over the course of one year, we monitored their health outcomes, particularly focusing on serious issues like cardiac death, heart attacks, and instances of scaffold thrombosis.
Surprisingly, we found that patients with Magmaris had significantly better outcomes than those with Absorb. Specifically, the rates of primary complications and target lesion failures were notably lower with Magmaris. We noted a concerning trend with Absorb, where patients experienced a higher rate of scaffold thrombosis.
Overall, our findings suggest that magnesium-based scaffolds could provide a safer and more effective option for patients undergoing treatment for heart attacks compared to their polymer counterparts.
Read More
8
Magnesium enhances heart attack recovery
We explored an innovative approach to treating myocardial infarction (MI) by using a special composite hydrogel that incorporates magnesium-modified black phosphorus nanosheets. This treatment aims to address the significant changes in the heart's environment after a heart attack, which are usually detrimental to recovery.
The research involved creating a hydrogel scaffold that allows for the gradual release of these magnesium-enhanced nanosheets directly at the site of the infarct. This is particularly important because sustained release helps to manage oxidative stress and inflammation, both common issues following a heart attack.
We observed that the black phosphorus nanosheets have a high reactivity with reactive oxygen species (ROS), which helps reduce oxidative stress and inflammation in the heart. Additionally, the magnesium contributes to promoting blood vessel growth, or angiogenesis, which is crucial for long-term heart function after an MI.
Overall, the findings of this study suggest that the combination of these elements in the hydrogel can effectively block further damage from the heart attack and improve recovery outcomes, signaling a promising avenue for heart attack treatments in the future.
The research involved creating a hydrogel scaffold that allows for the gradual release of these magnesium-enhanced nanosheets directly at the site of the infarct. This is particularly important because sustained release helps to manage oxidative stress and inflammation, both common issues following a heart attack.
We observed that the black phosphorus nanosheets have a high reactivity with reactive oxygen species (ROS), which helps reduce oxidative stress and inflammation in the heart. Additionally, the magnesium contributes to promoting blood vessel growth, or angiogenesis, which is crucial for long-term heart function after an MI.
Overall, the findings of this study suggest that the combination of these elements in the hydrogel can effectively block further damage from the heart attack and improve recovery outcomes, signaling a promising avenue for heart attack treatments in the future.
Read More
8
In our investigation, we set out to understand how magnesium lithospermate B (MLB) can aid heart repair following a heart attack. We used a mouse model with surgically induced myocardial infarction (MI) and categorized the mice into five groups, including those treated with MLB and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). By comparing different treatments, we evaluated the heart's recovery over four weeks through echocardiography and histochemical staining.
Our findings revealed that MLB significantly enhances the function of hiPSC-CMs, helping to repair the damaged heart muscle. This improvement happens by boosting the function of endothelial cells—important for blood vessel health—through a specific signaling pathway. Additionally, MLB decreases apoptosis, or cell death, in hiPSC-CMs by activating another pathway, which further supports heart recovery.
Overall, our work underscores the role of MLB in improving heart repair after a heart attack. While it was tested in tandem with hiPSC-CMs, which makes it an interesting combination for treatment strategies, it's clear that the integration of MLB can potentially enhance cardiac recovery mechanisms effectively.
Our findings revealed that MLB significantly enhances the function of hiPSC-CMs, helping to repair the damaged heart muscle. This improvement happens by boosting the function of endothelial cells—important for blood vessel health—through a specific signaling pathway. Additionally, MLB decreases apoptosis, or cell death, in hiPSC-CMs by activating another pathway, which further supports heart recovery.
Overall, our work underscores the role of MLB in improving heart repair after a heart attack. While it was tested in tandem with hiPSC-CMs, which makes it an interesting combination for treatment strategies, it's clear that the integration of MLB can potentially enhance cardiac recovery mechanisms effectively.
Read More
8
We explored how serum magnesium levels at the time of hospital admission affect the long-term health of patients experiencing a non-ST-elevation myocardial infarction (NSTEMI). In our analysis of data from over 4,500 patients, we focused on the differences between those with low serum magnesium levels—defined as below 1.9 mg/dL—and those with normal or higher levels.
Our findings indicate that patients with low magnesium levels were older, had more health complications like diabetes and hypertension, and faced a higher long-term risk of mortality. Specifically, we observed that 34% of patients with low magnesium levels died within four years, compared to 22% of those with adequate levels.
Importantly, even after adjusting for factors such as sex, existing health conditions, and interventions received during hospitalization, low serum magnesium levels still correlated with a significantly increased risk of death by 24%. While we revealed that low magnesium levels could be a concerning signal for NSTEMI patients, we did not assess the effects of magnesium treatment directly in this study.
Overall, this research brings to light the potential importance of monitoring magnesium levels in the clinical setting, highlighting how they may relate to long-term outcomes for heart attack patients.
Our findings indicate that patients with low magnesium levels were older, had more health complications like diabetes and hypertension, and faced a higher long-term risk of mortality. Specifically, we observed that 34% of patients with low magnesium levels died within four years, compared to 22% of those with adequate levels.
Importantly, even after adjusting for factors such as sex, existing health conditions, and interventions received during hospitalization, low serum magnesium levels still correlated with a significantly increased risk of death by 24%. While we revealed that low magnesium levels could be a concerning signal for NSTEMI patients, we did not assess the effects of magnesium treatment directly in this study.
Overall, this research brings to light the potential importance of monitoring magnesium levels in the clinical setting, highlighting how they may relate to long-term outcomes for heart attack patients.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 63 Reviews
7.6
- All Reviews
- Positive Reviews
- Negative Reviews
9
Supports heart function
138 people found this helpful
Following a heart attack, magnesium has been very beneficial for my body in maintaining normal cardiovascular function. I now take this supplement regularly to prevent future issues.
Read More
10
Palpitations relieved
24 people found this helpful
I felt almost debilitating heart palpitations for two years and was always worried about having a heart attack. After numerous medical tests, I tried this supplement and, within hours, my palpitations stopped. It has been life-changing! I feel much sharper and free of anxiety and am hopeful that I can maintain this health long-term.
Read More
9
Palpitations resolved
21 people found this helpful
I started taking magnesium to address heart palpitations caused by birth control pills. Since switching to this absorbed form, I've not experienced any incidents. Truly fantastic!
Read More
9
Palpitations eliminated
20 people found this helpful
After researching my symptoms, I realised I had a magnesium deficiency. After starting Doctor's Best chelated magnesium, my chest tightness, leg cramps, and insomnia vanished within two weeks. Even my 84-year-old mother has benefited from it, eliminating her night palpitations.
Read More
9
Stopped palpitations
15 people found this helpful
It worked! My palpitation was terrible, and I questioned whether it was due to menopause or heart disease. After drinking this 4-6 times a day, I stopped immediately! I also consume protein and various vitamins, but magnesium was what I needed.
Read More
Frequently Asked Questions
9
Palpitations eliminated
20 people found this helpful
After researching my symptoms, I realised I had a magnesium deficiency. After starting Doctor's Best chelated magnesium, my chest tightness, leg cramps, and insomnia vanished within two weeks. Even my 84-year-old mother has benefited from it, eliminating her night palpitations.
9
Positive heart stabilisation
2 people found this helpful
I am very satisfied with this supplement. For over a decade, I have suffered from arrhythmia and dyspnea, often relying on magnesium preparations. Unlike many pharmacy products that disappointed me, Magnesium from Doctor Best has improved my condition significantly. I noticed its effects after about a week, and my heart rate remains stable even with weather changes. This is a tremendous benefit for me, and I plan to continue taking the supplement.
9
Chest pain alleviated
1 people found this helpful
I suffered from panic attacks and severe chest pain. After a month on magnesium, my shoulder and neck spasms vanished, and the chest pain has significantly reduced. I highly recommend it.
9
Supports heart function
138 people found this helpful
Following a heart attack, magnesium has been very beneficial for my body in maintaining normal cardiovascular function. I now take this supplement regularly to prevent future issues.
9
Palpitations resolved
21 people found this helpful
I started taking magnesium to address heart palpitations caused by birth control pills. Since switching to this absorbed form, I've not experienced any incidents. Truly fantastic!
9
Atrial fibrillation aid
4 people found this helpful
I have successfully used Doctor's Best magnesium to manage my atrial fibrillation. I attribute my sustained arrhythmia-free period to it, as it is the most reliable glycinated product I’ve encountered for heart rhythm support.
0
Counterproductive supplement
5 people found this helpful
I suffer from heart palpitations, and after trying this supplement twice, I experienced worse palpitations. It does not suit me.
0
Sleep disruption
2 people found this helpful
This supplement caused me heart palpitations and disrupted my sleep, waking me up every night at 3am. I only took two tablets in the evenings.
9
Migraine relief
3 people found this helpful
After two months on magnesium, I haven’t suffered a single migraine attack! I also sleep without pills now, my mood has improved, and I feel less anxious. Magnesium truly feels like a miracle for me.
9
Visible benefits
1 people found this helpful
Magnesium aids bone growth, normalises my heart rate, lowers blood pressure, regulates blood sugar, reduces muscle cramps, and alleviates joint pain. After taking it, I noticed several benefits: I felt calmer, I sleep better, and my leg joints hurt less. The improvements are clearly noticeable.
9
Stopped palpitations
15 people found this helpful
It worked! My palpitation was terrible, and I questioned whether it was due to menopause or heart disease. After drinking this 4-6 times a day, I stopped immediately! I also consume protein and various vitamins, but magnesium was what I needed.
9
Extrasystole eliminated
11 people found this helpful
My extrasystole was awful, and it exhausted me daily. After trying magnesium from iHerb and taking one tablet twice daily, I noticed my heart no longer felt off rhythm. I returned to this dose after feeling dizzy with higher doses. When I paused, I felt my heart acting up again. I’ll stick to my dosage continuously.
9
Quick Relief
2 people found this helpful
This magnesium works effectively. An elderly woman experienced leg cramps at night, but they disappeared after taking two pills before bedtime. My husband's suspected arrhythmia has resolved since he started taking it. Although he needs a cardiogram for heart problems, this supplement has benefitted the whole family.
8
We explored how serum magnesium levels at the time of hospital admission affect the long-term health of patients experiencing a non-ST-elevation myocardial infarction (NSTEMI). In our analysis of data from over 4,500 patients, we focused on the differences between those with low serum magnesium levels—defined as below 1.9 mg/dL—and those with normal or higher levels.
Our findings indicate that patients with low magnesium levels were older, had more health complications like diabetes and hypertension, and faced a higher long-term risk of mortality. Specifically, we observed that 34% of patients with low magnesium levels died within four years, compared to 22% of those with adequate levels.
Importantly, even after adjusting for factors such as sex, existing health conditions, and interventions received during hospitalization, low serum magnesium levels still correlated with a significantly increased risk of death by 24%. While we revealed that low magnesium levels could be a concerning signal for NSTEMI patients, we did not assess the effects of magnesium treatment directly in this study.
Overall, this research brings to light the potential importance of monitoring magnesium levels in the clinical setting, highlighting how they may relate to long-term outcomes for heart attack patients.
Our findings indicate that patients with low magnesium levels were older, had more health complications like diabetes and hypertension, and faced a higher long-term risk of mortality. Specifically, we observed that 34% of patients with low magnesium levels died within four years, compared to 22% of those with adequate levels.
Importantly, even after adjusting for factors such as sex, existing health conditions, and interventions received during hospitalization, low serum magnesium levels still correlated with a significantly increased risk of death by 24%. While we revealed that low magnesium levels could be a concerning signal for NSTEMI patients, we did not assess the effects of magnesium treatment directly in this study.
Overall, this research brings to light the potential importance of monitoring magnesium levels in the clinical setting, highlighting how they may relate to long-term outcomes for heart attack patients.
7
We investigated how serum magnesium levels affect the risk of acute kidney injury (AKI) in patients who experienced ST segment elevation myocardial infarction (STEMI), a severe type of heart attack. In our study, we reviewed data from 1,219 patients, dividing them into two groups: those with hypomagnesemia (low magnesium levels) and those without. Hypomagnesemia was specifically defined as having a serum magnesium level of less than 0.75 mmol/L, a threshold that indicates deficiency.
Out of the participants, we found that 163 patients (about 13.4%) were hypomagnesemic, and alarmingly, 256 patients (21.0%) developed AKI during their hospital stay. The figures showed a significant disparity: AKI occurred in 31.9% of the hypomagnesemia group compared to 19.3% of those with normal magnesium levels, signaling a concerning association.
Our analysis indicated that hypomagnesemia is an independent risk factor for developing AKI, with a calculated odds ratio of 2.41. This suggests that patients with lower magnesium at admission face more than double the risk of experiencing kidney complications. These findings highlight the potential for magnesium interventions in heart attack recovery, suggesting that monitoring and managing magnesium levels could play a crucial role in improving patient outcomes and reducing the risk of kidney injury after a heart attack.
Out of the participants, we found that 163 patients (about 13.4%) were hypomagnesemic, and alarmingly, 256 patients (21.0%) developed AKI during their hospital stay. The figures showed a significant disparity: AKI occurred in 31.9% of the hypomagnesemia group compared to 19.3% of those with normal magnesium levels, signaling a concerning association.
Our analysis indicated that hypomagnesemia is an independent risk factor for developing AKI, with a calculated odds ratio of 2.41. This suggests that patients with lower magnesium at admission face more than double the risk of experiencing kidney complications. These findings highlight the potential for magnesium interventions in heart attack recovery, suggesting that monitoring and managing magnesium levels could play a crucial role in improving patient outcomes and reducing the risk of kidney injury after a heart attack.
4
We delved into a clinical trial that explored the long-term effectiveness of magnesium-based resorbable scaffolds in patients who suffered from ST-segment elevation myocardial infarction, commonly known as heart attack. In this study, we compared these magnesium scaffolds to permanent metal stents that release sirolimus, a drug designed to prevent artery blockage. The research involved a randomized and single-blind approach, including 11 academic centers and focusing on various health outcomes for up to three years.
Over the follow-up period, we observed that patients with magnesium scaffolds experienced a higher rate of device-related complications known as device-oriented composite endpoints (DoCE) compared to those with the permanent metal stents. Interestingly, most of these complications were noted within the first year of treatment. Specifically, the need for additional procedures to reopen blocked arteries, or target lesion revascularization (TLR), was significantly more common in the group with magnesium scaffolds during the first year.
While magnesium scaffolds present a novel approach to treating heart attacks, our findings suggest that they are not as effective as permanent stents in reducing complications in the long run. Therefore, while they offer a unique solution, their performance raises questions that need further exploration in future studies.
Over the follow-up period, we observed that patients with magnesium scaffolds experienced a higher rate of device-related complications known as device-oriented composite endpoints (DoCE) compared to those with the permanent metal stents. Interestingly, most of these complications were noted within the first year of treatment. Specifically, the need for additional procedures to reopen blocked arteries, or target lesion revascularization (TLR), was significantly more common in the group with magnesium scaffolds during the first year.
While magnesium scaffolds present a novel approach to treating heart attacks, our findings suggest that they are not as effective as permanent stents in reducing complications in the long run. Therefore, while they offer a unique solution, their performance raises questions that need further exploration in future studies.
References
- Demirtola Aİ, Mammadli A, Çiçek G. The Role of Magnesium Levels in the Progression of Contrast-Induced Nephropathy in Patients With STEMI Undergoing Primary PCI. Angiology. 2025. 10.1177/00033197251314629
- Jin Y, Lin Q, Wang D, Gong M, Huang W, et al. Hypomagnesemia is a Risk Factor for Acute Kidney Injury in Patients Admitted With ST-Segment Elevation Myocardial Infarction: A Retrospective Observational Study. J Ren Nutr. 2024. 10.1053/j.jrn.2024.12.006
- Naveen V, Rajesh Lenin R, Stanley LM, Kumar JS. Serum Magnesium Levels and QTc Interval Prolongation As Prognostic Markers in Acute Myocardial Infarction: A Randomized Controlled Study. Cureus. 2024;16:e66051. 10.7759/cureus.66051
- Zhuang J, Zhang Q, Wang H, Su PH, Chen PY. Association between short-term changes in serum magnesium and in-hospital mortality following acute myocardial infarction: a cohort study based on the MIMIC database. Magnes Res. 2024;37:45. 10.1684/mrh.2024.0517
- Zhang J, Sun D, Guo Y, Tong J, Liu Q, et al. Targeted delivery of black phosphorus nanosheets by ROS responsive complex hydrogel based on angiogenesis and antioxidant promotes myocardial infarction repair. J Nanobiotechnology. 2024;22:433. 10.1186/s12951-024-02685-0
- Wang B, Pan S, Nie C, Zou R, Liu J, et al. Magnesium implantation as a continuous hydrogen production generator for the treatment of myocardial infarction in rats. Sci Rep. 2024;14:10959. 10.1038/s41598-024-60609-2
- Fan C, Qin K, Iroegbu CD, Xiang K, Gong Y, et al. Magnesium lithospermate B enhances the potential of human-induced pluripotent stem cell-derived cardiomyocytes for myocardial repair. Chin Med J (Engl). 2024;137:1857. 10.1097/CM9.0000000000002867
- Segev A, Shechter M, Tsur AM, Belkin D, Cohen H, et al. Serum Magnesium Is Associated with Long-Term Survival of Non-ST-Elevation Myocardial Infarction Patients. Nutrients. 2023;15. 10.3390/nu15194299
- Włodarczak A, Rola P, Barycki M, Furtan Ł, Łanocha M, et al. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds - magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort. Diab Vasc Dis Res. 2023;20:14791641231188705. 10.1177/14791641231188705
- Sabah Z, Wani J, Deajim M, Al Zomia AS, Asiri A, et al. Serum Magnesium in Patients With Acute Myocardial Infarction and Its Effect on Cardiac Complications and Mortality in Myocardial Infarction Patients. Cureus. 2023;15:e38147. 10.7759/cureus.38147
- An P, Wan S, Luo Y, Luo J, Zhang X, et al. Micronutrient Supplementation to Reduce Cardiovascular Risk. J Am Coll Cardiol. 2022;80:2269. 10.1016/j.jacc.2022.09.048
- Evers I, Cruijsen E, Kornaat I, Winkels RM, Busstra MC, et al. Dietary magnesium and risk of cardiovascular and all-cause mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort. Front Cardiovasc Med. 2022;9:936772. 10.3389/fcvm.2022.936772
- Rola P, Włodarczak A, Łanocha M, Barycki M, Szudrowicz M, et al. Outcomes of the two generations of bioresorbable scaffolds (Magmaris vs. Absorb) in acute coronary syndrome in routine clinical practice. Cardiol J. 2022;30:870. 10.5603/CJ.a2022.0047
- Ortega-Paz L, Brugaletta S, Gomez-Lara J, Alfonso F, Cequier A, et al. Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial. EuroIntervention. 2022;18:e389. 10.4244/EIJ-D-21-00651
- Hasan MZ, Nahar K, Sharif JU, Paul SC, Thakur AK, et al. Serum Magnesium Level and It's Relation in Predicting Adverse In-Hospital Outcome in Patients with First Attack of Myocardial Infarction. Mymensingh Med J. 2023;32:65.
- Fallesen CO, Antonsen L, Maehara A, Noori M, Hougaard M, et al. Optical Coherence Tomography- Versus Angiography-Guided Magnesium Bioresorbable Scaffold Implantation in NSTEMI Patients. Cardiovasc Revasc Med. 2022;40:101. 10.1016/j.carrev.2021.12.003
- Włodarczak A, Łanocha M, Lesiak M, Benett J, Szudrowicz M, et al. Long-term clinical follow-up of the resorbable magnesium scaffolds in acute coronary syndrome patients. Kardiol Pol. 2021;79:827. 10.33963/KP.a2021.0035
- Açıkgöz E, Açıkgöz SK, Çiçek G. Serum magnesium concentration may predict no-reflow phenomenon in primary angioplasty for ST-elevation myocardial infarction. Magnes Res. 2020;33:123. 10.1684/mrh.2021.0477
- Shlezinger M, Amitai Y, Goldenberg I, Atar S, Shechter M. Acute myocardial infarction severity, complications, and mortality associated with lack of magnesium intake through consumption of desalinated seawater. Magnes Res. 2019;32:39. 10.1684/mrh.2019.0449
- Sabaté M, Alfonso F, Cequier A, Romaní S, Bordes P, et al. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial. Circulation. 2019;140:1904. 10.1161/CIRCULATIONAHA.119.043467
- Ielasi A, Cerrato E, Geraci S, Campo G, Garro N, et al. Sirolimus-Eluting Magnesium Resorbable Scaffold Implantation in Patients with Acute Myocardial Infarction. Cardiology. 2019;142:93. 10.1159/000499536
- Lee TM, Chang NC, Lin SZ. Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium. PLoS One. 2018;13:e0202979. 10.1371/journal.pone.0202979
- de Hemptinne Q, Picard F, Briki R, Awada A, Silance PG, et al. Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study. J Invasive Cardiol. 2018;30:202.
